June 29, 2022 Sophia Vida

Odyssey Health, Inc. Completes Safety Evaluation of Cohort II for Concussion Drug

  Las Vegas, NV, June 29, 2022 — McapMediaWire — Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, a company focused on developing unique, life-saving medical products, today announced positive safety findings from Cohort II of their Phase I clinical trial. Odyssey’s trial involves administering PRV-002, the Company’s novel drug to treat concussion, to … Continue reading “Odyssey Health, Inc. Completes Safety Evaluation of Cohort II for Concussion Drug”